NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Circulating tumor cells and sample size: the more, the better.

Author(s): Lalmahomed ZS, Kraan J, Gratama JW, Mostert B, Sleijfer S, Verhoef C

Publication: J Clin Oncol, 2010, Vol. 28, Page e288-9; author reply e290

PubMed ID: 20439640 PubMed Review Paper? No

Purpose of Paper

This paper explored how the volume of peripheral blood used may influence the number of circulating tumor cells (CTCs) detected by the CellSearch method.

Conclusion of Paper

Analysis of 30 mL aliquots of peripheral blood by CellSearch yielded higher CTC counts as well as a higher percentage of patients with ≥1 CTCs per aliquot and ≥3 CTCs per aliquot than when 7.5 mL aliquots were analyzed by the same methods.

Studies

  1. Study Purpose

    This study explored how the volume of peripheral blood used may influence the number of CTCs detected by the CellSearch method. Forty mL of peripheral arterial blood was collected in 10 mL CellSave tubes from 15 patients undergoing liver resection and/or open radio frequency ablation prior to surgery. Blood was pooled, stored at room temperature, and processed within 72 hours of collection. A 30 ml aliquot and a 7.5 ml aliquot was analyzed for each patient. Each 30 ml aliquot was subjected to a modified Ficoll density gradient separation, which resulted in a reduced volume of 7.5 mL of enriched blood to permit analysis by CellSearch.

    Summary of Findings:

    The median number of CTCs recovered from peripheral blood was statistically higher for 30 mL aliquots than 7.5 mL aliquots (two CTCs versus one CTC, range 0-9 versus 0-4, P=.03) and the median paired difference between the two volumes was one (range of -1 to 7). Further, CTCs were detected in a higher percentage of patients when using blood enriched from a 30 mL aliquot compared to the 7.5 mL aliquot (≥1 CTC were detected in 87% versus 67% of patients and ≥3 CTCs detected in 47% compared to 13% of patients, respectively).

    Biospecimens
    Preservative Types
    • Other Preservative
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Light microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Aliquot size/volume 7.5 mL
    30 mL

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...